Recurrence of Lung Clot: Prevented By a Low Dose of Aspirin

Recommend to others!

Many individuals who suffered from clotting abnormalities, such as presence of clots in the lungs and other significant parts of the body are more predisposed in having another episode of clotting issues in the future. The problem of clots present in different body parts is that the blood supply to that specific body part is obstructed leading to the clinical manifestations of the illness.

This health problem is faced by many individuals who had successful treatment of the removal of clots. For this reason, the goal of many health care professionals is to lessen the health risk of these individuals to have another episode of lung clots. Many treatment options are being tried such as administration of blood thinners. In fact, recently, according to a new study, administration of aspirin in a low dose can actually prevent the recurrence of lung clots.

Aspirin or also known as acetylsalicylic acid (ASA) is a medication which has an analgesic effect which means that the drug can relieve minor pain sensations; the drug is also considered as antipyretic because it can reduce fever to some extent, and lastly, the drug is also used as an anti-inflammatory medication. More so, researchers found out that this drug has an anti-platelet effect. This means that the drug is capable of inhibiting the development of blood clots.

The new study was slated to be presented Saturday at the annual meeting of the American Society of Hematology (ASH) in San Diego. Also, the data presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

The Italian researchers deemed to examine the effectiveness of administration of aspirin in a low dose for about two years in preventing the recurrence of blood clots in the lungs. The new study involved the analysis and examination of data gathered from about a total of 402 study participants.

The study participants were divided into two. The first half is receiving low dose of aspirin, while the other is receiving a placebo. Researchers found out that the recurrence among those individuals who are taking aspirin is about (6.6 per cent) 28 or about out of the 205 patients. That is compared to about (11.2 per cent) 43 patients who had recurrence out of the 197 patients who received placebo.

Moreover, according to lead author Dr. Cecilia Becattini, an assistant professor of internal medicine in the Internal and Cardiovascular Medicine and Stroke Unit at the University of Perugia, she said: “Our study shows that aspirin, a common and low-cost drug found in most medicine cabinets, can be a valid alternative to oral anticoagulants for the extended treatment of VTE.”




Speak Your Mind


Current day month ye@r *